or Try an Advanced Search...

    ETF Components for BBC - Virtus LifeSci Biotech Clinical Trials ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ALPN A -0.09 2.89
    VKTX B 7.91 2.86
    RNA A 2.22 2.65
    VERA D 2.48 2.27
    DYN C 4.37 1.82
    SANA C 2.59 1.72
    CGEM A 31.43 1.66
    CYTK D 0.83 1.52
    LQDA D 1.29 1.50
    MGNX D 1.32 1.48
    KROS C 6.77 1.38
    MRUS B 0.24 1.37
    NRIX B 0.00 1.34
    GERN A 6.46 1.34
    KURA C 3.42 1.33
    IOVA D 0.87 1.30
    BCYC C 0.93 1.28
    FDMT D -1.19 1.26
    COGT F 0.17 1.19
    KYMR D 0.06 1.19
    SMMT C 8.73 1.19
    KRYS D 0.77 1.18
    MLYS C 7.52 1.17
    RVMD A 1.78 1.17
    PTGX D 1.99 1.09
    CRNX B -0.40 1.07
    INBX D -0.09 1.05
    ALLO F 1.23 1.05
    LYEL C -1.36 1.02
    IGMS D 22.88 1.00
    DAWN D 12.94 0.99
    ALXO A -0.06 0.99
    IDYA C 3.42 0.97
    PGEN C 0.71 0.94
    ARDX D 1.74 0.93
    ACLX D 1.05 0.90
    IMTX F 2.35 0.90
    CMPS F 1.02 0.90
    SNDX C 2.38 0.89
    CLDX D 0.11 0.88
    PHAT F 0.88 0.86
    ITOS F 1.89 0.86
    PCVX D 1.10 0.85
    ANAB C 11.29 0.85
    ARCT F 1.45 0.84
    XENE D 1.00 0.84
    MORF F 0.32 0.82
    ARVN D 2.44 0.81
    ORIC F 5.22 0.81
    AKRO F 4.28 0.80
    MDGL F -0.54 0.78
    RCUS D 5.57 0.74
    DVAX F 0.36 0.73
    XNCR D 3.90 0.73
    NUVL C 1.20 0.72
    BLTE C 4.61 0.71
    RCKT F -0.54 0.71
    ZNTL F 0.68 0.71
    REPL F 4.39 0.70
    ETNB F 0.12 0.70
    ARWR F 1.14 0.70
    OLMA F 1.22 0.69
    RXRX F 3.57 0.68
    VIR F 7.86 0.68
    BEAM F -1.02 0.67
    TGTX F -3.16 0.67
    SRRK C 4.08 0.67
    BMEA F 2.96 0.66
    RGNX F 0.81 0.65
    PLRX F -0.59 0.63
    NVAX F 3.54 0.62
    VRDN F 1.42 0.62
    TERN F 5.82 0.61
    ABCL F 3.58 0.61
    DNLI F 3.14 0.59
    SAVA B 2.81 0.58
    IMVT F -2.09 0.57
    NTLA F 3.70 0.57
    ALEC D 9.15 0.56
    CRBU F -1.33 0.55
    CABA F -9.61 0.55
    QURE F -0.22 0.50
    RLAY F 3.49 0.50
    PRTA F 1.51 0.45
    EDIT F 1.92 0.43
    VERV F -0.96 0.41
    IRON F 3.88 0.39
    CVAC F 0.87 0.38
    RAPT F 3.85 0.35
    ALLK F 0.99 0.28

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Clinical Medicine Life Sciences Solid Tumors Disease Immune System Biology Immunology Antibodies Treatment Of Cancer Clinical Development Cancer Treatment Genetics Medication Monoclonal Antibodies Autoimmune Disease Cancer Immunotherapy
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities

    Recent News for Virtus LifeSci Biotech Clinical Trials ETF & its Holdings

    Date Stock Title
    Apr 26 CGEM Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Apr 26 EDIT Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
    Apr 26 ARVN Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    Apr 26 ALLO Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
    Apr 26 VKTX Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
    Apr 26 MRUS Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?
    Apr 26 ARWR Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
    Apr 26 KRYS Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
    Apr 26 BLTE Belite Bio prices $25M direct offering
    Apr 25 BLTE Belite Bio Announces $25 Million Registered Direct Offering
    Apr 25 RXRX Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors
    Apr 25 GERN Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
    Apr 25 RLAY Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
    Apr 25 ARCT Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
    Apr 25 CVAC CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
    Apr 25 CMPS COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?
    Apr 25 NTLA Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
    Apr 25 IOVA 3 Millionaire-Maker Biotech Stocks
    Apr 25 RXRX 3 Millionaire-Maker Biotech Stocks
    Apr 25 VKTX 3 Millionaire-Maker Biotech Stocks
    The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
    Biotechnology Health Sciences Drug Discovery Pharmacology Clinical Research Clinical Trial
    Back to the Main BBC Page...